Literature DB >> 7024116

Effect of the TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice.

E H Goldberg, G Goldstein, E A Boyse, M P Scheid.   

Abstract

Although young adult C3H/HeJ (C3H) females do not reject C3H male skin grafts, C3H females older than 1 year commonly do so, as also do many thymectomized, young adult C3H females. Therapy with TP5, a synthetic pentapeptide analogue of thymopoietin which has biological properties of the parent molecule, substantially reduced the capacity of aged C3H females and of thymectomized, young C3H females to reject C3H male skin.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7024116     DOI： 10.1007/bf00350786

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


  6 in total

1.  Production of H-Y antibody by female mice that fail to reject male skin.

Authors:  E Goldberg; E A Boyse; M Scheid; D Bennett
Journal:  Nat New Biol       Date:  1972-07-12

2.  Regulation of cellular and humoral immune responses by T-cell subclasses.

Authors:  H Cantor; E A Boyse
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

3.  Age, thymic involution, and circulating thymic hormone activity.

Authors:  V M Lewis; J J Twomey; P Bealmear; G Goldstein; R A Good
Journal:  J Clin Endocrinol Metab       Date:  1978-07       Impact factor: 5.958

4.  A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.

Authors:  G Goldstein; M P Scheid; E A Boyse; D H Schlesinger; J Van Wauwe
Journal:  Science       Date:  1979-06-22       Impact factor: 47.728

5.  Immunological studies of aging. IV. The contribution of thymic involution to the immune deficiencies of aging mice and reversal with thymopoietin32-36.

Authors:  M C Weksler; J D Innes; G Goldstein
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

6.  Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition.

Authors:  D D Eardley; J Hugenberger; L McVay-Boudreau; F W Shen; R K Gershon; H Cantor
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307
  6 in total
  8 in total

1.  Thymopentin: stability considerations and potency by various routes of administration.

Authors:  T K Audhya; G Goldstein
Journal:  Surv Immunol Res       Date:  1985

2.  Prevention of recurrences in frequently relapsing herpes labialis with thymopentin. A randomized double-blind placebo-controlled multicenter study.

Authors:  K Bolla; D Djawari; E M Kokoschka; J Petres; S Lidén; R Gonseth; P Amblard; M G Bernengo; J J Bonerandi; A Claudy
Journal:  Surv Immunol Res       Date:  1985

3.  In vitro influence of thymopentin on proliferative responses and phytohemagglutinin-induced interleukin 2 production in normal human lymphocyte cultures.

Authors:  J Duchateau; G Servais; R Cooman; H Collet; K Bolla
Journal:  Surv Immunol Res       Date:  1985

4.  Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen.

Authors:  T Audhya; M P Scheid; G Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 5.  Thymopoietin to thymopentin: experimental studies.

Authors:  G Goldstein; T K Audhya
Journal:  Surv Immunol Res       Date:  1985

Review 6.  Thymopentin and splenopentin as immunomodulators. Current status.

Authors:  V K Singh; S Biswas; K B Mathur; W Haq; S K Garg; S S Agarwal
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

7.  Influence of the thymus on the capacity of female mice to reject male skin grafts.

Authors:  E S De Pirro; E H Goldberg
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

8.  T cell development in normal and thymopentin-treated nude mice.

Authors:  G E Ranges; G Goldstein; E A Boyse; M P Schield
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.